rethinkPeptides Search
Menu
RethinkPeptides

Research library — page 23

Browse more peptide research, methods and limitations.

Filter by topic, method, and evidence

You can select more than one topic or evidence level.

Clear filters

RPEP-01318 · 2008

Surprising: GHRH Can Also Activate the Ghrelin Receptor

GHRH demonstrated agonist activity at the GHS-R1a (ghrelin receptor) at physiologically relevant concentrations, revealing previously unknown cross-talk between the GHRH and ghrelin receptor systems — explaining some synergistic GH-releasing effects.

Casanueva, Felipe F; Camiña, Jesus P; Carreira, Marcos C; Pazos, Yolanda; Varga, Jozsef L; Schally, Andrew V · In Vitro

RPEP-01320 · 2008

N-Methylation of Peptides: A Key Chemical Strategy for Making Oral Peptide Drugs

N-methylation of peptide backbone amides improves oral bioavailability, proteolytic stability, membrane permeability, and conformational rigidity — the key chemical modification enabling oral peptide drugs, validated by cyclosporine and being applied to new therapeutic peptides.

Chatterjee, Jayanta; Gilon, Chaim; Hoffman, Amnon; Kessler, Horst · Review

RPEP-01321 · 2008

Smart Peptide Scaffolds: Self-Assembling Gels That Respond to Wound Healing Enzymes

Self-assembling peptide hydrogels incorporating matrix metalloproteinase (MMP)-sensitive substrate sequences degraded in response to cell-secreted MMPs during tissue repair, creating enzyme-responsive smart scaffolds that adapt to the wound healing environment.

Chau, Ying; Luo, Ying; Cheung, Alex C Y; Nagai, Yusuke; Zhang, Shuguang; Kobler, James B; Zeitels, Steven M; Langer, Robert · In Vitro

RPEP-01323 · 2008

Mass-Producing Thymosin Alpha-1 in Bacteria Using Concatemer Gene Technology

Thymosin alpha-1 concatemer expression in E. coli produced multiple peptide copies per fusion protein, with enzymatic cleavage releasing biologically active thymosin alpha-1 — a high-yield manufacturing strategy for this clinical peptide drug.

Chen, Yuhui; Zhao, Lingxia; Shen, Guoan; Cui, Lijie; Ren, Weiwei; Zhang, Hui; Qian, Hongmei; Tang, Kexuan · In Vitro

RPEP-01325 · 2008

Kisspeptin: The Brain's Master Switch for Puberty and Fertility Through GPR54

Kisspeptins activate GPR54 receptor to control GnRH neuron firing, serving as the essential gatekeeper for puberty onset and adult fertility — GPR54 mutations cause both absent puberty (hypogonadotropic hypogonadism) and infertility, establishing kisspeptin as the master reproductive switch.

Colledge, W H · Review

RPEP-01326 · 2008

Contaminated Peptides from Commercial Suppliers Can Produce False-Positive Results in Vaccine Trials

Peptide library sets designed for HIV vaccine immune response testing, obtained from two independent custom peptide suppliers, contained contaminating peptides capable of generating false-positive results mimicking antigen-specific CD8+ T-cell responses. Detailed investigation revealed that an HIV-1 peptide was contaminated with approximately 1% by weight of a human cytomegalovirus (HCMV) peptide commonly used in cellular immunology research. Because HCMV infection is widespread in the population, this contamination triggered genuine but irrelevant T-cell responses that appeared to be HIV-specific. The false positives were consistent enough to mimic real vaccine-induced responses, which could have led to incorrect conclusions about vaccine efficacy.

Currier, Jeffrey R; Galley, Lynee M; Wenschuh, Holger; Morafo, Vivian; Ratto-Kim, Silvia; Gray, Clive M; Maboko, Leonard; Hoelscher, Michael; Marovich, Mary A; Cox, Josephine H ·

RPEP-01327 · 2008

How the Tripeptide KPV Gets Into Gut Cells and Reduces Intestinal Inflammation

KPV (Lys-Pro-Val) enters intestinal epithelial cells and immune cells — including macrophages, T cells, and B cells — via the PepT1 peptide transporter. Once inside, KPV inhibited NF-kappaB activation and reduced IL-8 secretion in cells exposed to TNF-alpha. When PepT1 was silenced with siRNA, these anti-inflammatory effects were abolished. In live mice, oral KPV reduced inflammation in both DSS-induced and TNBS-induced colitis models, as shown by decreased proinflammatory cytokine expression. Critically, PepT1 knockout mice showed no benefit from KPV, confirming that PepT1 is required for the peptide's anti-inflammatory action. This overturns the prior assumption that KPV works through melanocortin receptors.

Dalmasso, Guillaume; Charrier-Hisamuddin, Laetitia; Nguyen, Hang Thi Thu; Yan, Yutao; Sitaraman, Shanthi; Merlin, Didier · Animal Study

RPEP-01330 · 2008

Anti-Inflammatory Neuropeptides: The Body's Own Class of Immune-Regulating Drugs

Anti-inflammatory neuropeptides (VIP, PACAP, alpha-MSH/KPV, CGRP, cortistatin) constitute an endogenous immunoregulatory system: generating regulatory T-cells, suppressing pathogenic Th1/Th17 responses, and promoting inflammation resolution — nature's own anti-inflammatory drug class.

Delgado, Mario; Ganea, Doina · Review

RPEP-01331 · 2008

VIP Receptor Genetic Variants Linked to Rheumatoid Arthritis

VPAC1 receptor gene polymorphisms were associated with RA susceptibility, with RA patients showing altered VIP receptor expression and signaling — providing genetic evidence linking the neuropeptide anti-inflammatory system to autoimmune disease pathogenesis.

Delgado, Mario; Robledo, Gema; Rueda, Blanca; Varela, Nieves; O'Valle, Francisco; Hernandez-Cortes, Pedro; Caro, Marta; Orozco, Gisela; Gonzalez-Rey, Elena; Martin, Javier · Clinical Trial

RPEP-01332 · 2008

Gene Therapy Delivering VIP to Joints Treats Collagen-Induced Arthritis in Mice

Lentiviral VIP gene delivery to arthritic joints reduced inflammation, cartilage destruction, and bone erosion in collagen-induced arthritis mice — demonstrating neuropeptide gene therapy as a viable approach for local treatment of autoimmune joint disease.

Delgado, Mario; Toscano, Miguel G; Benabdellah, Karim; Cobo, Marien; O'Valle, Francisco; Gonzalez-Rey, Elena; Martín, Francisco · Animal Study

RPEP-01333 · 2008

Long-Term Ghrelin Exposure Changes Calcium Channels in Pituitary Cells

Chronic ghrelin/GHRP exposure upregulated L-type and T-type high-voltage calcium channels in GC somatotrophs, enhancing calcium-dependent GH exocytosis capacity — a mechanism for sustained or increasing GH response during chronic secretagogue treatment.

Dominguez, Belisario; Avila, Traudy; Flores-Hernandez, Jorge; Lopez-Lopez, Gustavo; Martinez-Rodriguez, Herminia; Felix, Ricardo; Monjaraz, Eduardo · In Vitro

RPEP-01334 · 2008

Tumstatin Peptide Starves Tumors of Blood Supply and Works Even Better When Combined with Bevacizumab

Researchers identified three specific amino acids — leucine (L), valine (V), and aspartic acid (D) — as essential for the anti-angiogenic activity of tumstatin, a peptide derived from collagen type IV that inhibits blood vessel growth in tumors. A 25-amino acid fragment of tumstatin, when administered systemically, inhibited tumor growth and angiogenesis in mice. The peptide binds specifically to αvβ3 integrin on proliferating endothelial cells and localizes to tumor blood vessels in vivo. When combined with bevacizumab (the anti-VEGF antibody), the tumstatin peptide showed significantly improved anti-tumor efficacy against human renal cell carcinoma xenografts compared to either agent alone.

Eikesdal, Hans Petter; Sugimoto, Hikaru; Birrane, Gabriel; Maeshima, Yohei; Cooke, Vesselina G; Kieran, Mark; Kalluri, Raghu ·

RPEP-01336 · 2008

Blocking Fat Absorption With Orlistat Increases Appetite and Reduces GLP-1: Gut Fat Signal Explained

Orlistat inhibition of intestinal lipase acutely increased appetite and attenuated GLP-1/PYY satiety responses, proving that fat absorption (not just fat presence) is required for satiety hormone release — the gut must PROCESS fat to signal fullness.

Ellrichmann, Mark; Kapelle, Mario; Ritter, Peter R; Holst, Jens J; Herzig, Karl-Heinz; Schmidt, Wolfgang E; Schmitz, Frank; Meier, Juris J · RCT

RPEP-01338 · 2008

Digested Proteins Release Peptides That Trigger CCK From Gut Hormone Cells

Protein hydrolysates directly stimulated CCK secretion from STC-1 enteroendocrine cells and showed partial CCK1 receptor agonist activity, demonstrating dual mechanisms: dietary peptides both trigger satiety hormone release AND directly activate satiety receptors.

Foltz, Martin; Ansems, Patrick; Schwarz, Jessica; Tasker, Maria C; Lourbakos, Afrodite; Gerhardt, Cindy C · In Vitro

RPEP-01339 · 2008

Lactoferricin Kills Leukemia Cells by Triggering the Ceramide Death Pathway

Lactoferricin B induced leukemia cell apoptosis through ceramide accumulation, and modulating ceramide metabolism (glucocerebrosidase inhibition) potentiated the killing — identifying the ceramide death pathway as the molecular mechanism for this anticancer peptide.

Furlong, Suzanne J; Ridgway, Neale D; Hoskin, David W · In Vitro

RPEP-01340 · 2008

Self-Assembling Peptide Nanofiber Scaffolds Support Dental Stem Cell Growth

Peptide amphiphile nanofibers self-assembled into scaffolds supporting dental stem cell (DPSC) adhesion, proliferation, and odontogenic differentiation — validating self-assembling peptide biomaterials for injectable dental tissue regeneration applications.

Galler, Kerstin M; Cavender, Adriana; Yuwono, Virany; Dong, He; Shi, Songtao; Schmalz, Gottfried; Hartgerink, Jeffrey D; D'Souza, Rena N · In Vitro

RPEP-01343 · 2008

BNP and proBNP: Guide Therapy and Predict Outcomes in Cardiovascular Disease

BNP and NT-proBNP serve dual clinical roles: guiding heart failure drug therapy (titration endpoints) and predicting cardiovascular outcomes (mortality, hospitalization risk) — established as essential biomarkers in evidence-based cardiovascular care.

Godkar, Darshan; Bachu, Kalyan; Dave, Bijal; Niranjan, Selva; Khanna, Ashok · Review

RPEP-01344 · 2008

GHRP-2 Protects the Liver From Endotoxin-Induced Inflammation

GHRP-2 administration prevented endotoxin-induced liver inflammation in rats: reduced hepatic TNF-α, IL-1β, IL-6, and NF-κB activation — demonstrating direct anti-inflammatory hepatoprotection by GH secretagogues independent of GH release.

Granado, Miriam; Martín, Ana Isabel; López-Menduiña, María; López-Calderón, Asunción; Villanúa, M Angeles · Animal Study

RPEP-01345 · 2008

How Modified Lactoferricin Peptides Interact With Bacterial Membrane Lipids: NMR Study

Solid-state NMR revealed acylated, tryptophan-methylated lactoferricin peptides inserted deeper into lipid bilayers with stronger membrane disruption, providing molecular-level explanation for how chemical modifications enhance antimicrobial potency.

Greathouse, Denise; Vostrikov, Vitaly; McClellan, Nicole; Chipollini, Juan; Lay, Jack; Liyanage, Rohana; Ladd, Taylor · In Vitro

RPEP-01346 · 2008

Macrocyclic Melanocortin Agonists: New Ring-Shaped Peptides for Sexual Dysfunction and Beyond

Novel macrocyclic melanocortin peptides synthesized by microwave-assisted methods showed potent MC1R/MC4R activity, with the macrocyclic constraint improving receptor selectivity and metabolic stability — advancing circular peptide drugs for melanocortin receptor-mediated therapies.

Grieco, Paolo; Cai, Minying; Liu, Lu; Mayorov, Alexander; Chandler, Kevin; Trivedi, Dev; Lin, Guangxin; Campiglia, Pietro; Novellino, Ettore; Hruby, Victor J · In Vitro

RPEP-01347 · 2008

Early Life Environment Permanently Shapes Brain Opioid Peptides Through Adulthood

Postnatal environment quality produced lasting changes in brain opioid peptide levels (dynorphin, enkephalin) across development into adulthood in Wistar rats, demonstrating enduring early-life programming of the opioid system that may predispose to later psychopathology.

Gustafsson, Lisa; Oreland, Sadia; Hoffmann, Pernilla; Nylander, Ingrid · Animal Study

RPEP-01348 · 2008

VIP Regulates Human T-Cell Subsets Differently: Implications for Rheumatoid Arthritis Treatment

VIP differentially modulated human T-cell subsets: suppressed CD4+ effector T-cell proliferation/activation while supporting CD4+CD25+ regulatory T-cell function and survival — directly applicable to restoring the effector/regulatory T-cell balance in rheumatoid arthritis.

Gutiérrez-Cañas, Irene; Juarranz, Yasmina; Santiago, Begoña; Martínez, Carmen; Gomariz, Rosa P; Pablos, José Luis; Leceta, Javier · In Vitro

RPEP-01350 · 2008

How Antimicrobial Peptide-Resistant Brucella Behaves in Mouse Infection Models

Polymyxin B-resistant Brucella abortus showed modified defensin susceptibility and altered colonization in mice, demonstrating that antimicrobial peptide resistance affects bacterial fitness, virulence, and tissue tropism in vivo — not just simple survival.

Halling, Shirley M; Jensen, Allen E; Olsen, Steven C · Animal Study

RPEP-01351 · 2008

Self-Assembling Peptide Gels Enable Bone Formation From Stem Cells in 3D Culture

Marrow mesenchymal stem cells in self-assembling peptide hydrogels produced spatially organized mineralized bone matrix resembling natural trabecular bone distribution, demonstrating peptide scaffolds can guide not just cell growth but organized bone tissue formation.

Hamada, Kazunori; Hirose, Motohiro; Yamashita, Toshihiko; Ohgushi, Hajime · In Vitro

RPEP-01353 · 2008

Strategies for Locking Peptides Into Alpha-Helix Shape: A Drug Design Review

Contemporary helix stabilization strategies include hydrocarbon stapling, hydrogen bond surrogates, salt bridges, disulfide crosslinks, and unnatural amino acids — chemical approaches that lock therapeutic peptides into bioactive helical conformations for clinical development.

Henchey, Laura K; Jochim, Andrea L; Arora, Paramjit S · Review

RPEP-01354 · 2008

Short Cationic Antimicrobial Peptides: How to Screen, Optimize, and Predict Activity

Short linear cationic antimicrobial peptides (≤25 residues) can be systematically screened, optimized through SAR rules (charge, hydrophobicity, amphipathicity), and computationally predicted for activity — a practical framework for antimicrobial peptide drug development.

Hilpert, Kai; Fjell, Christopher D; Cherkasov, Artem · Review

RPEP-01355 · 2008

Gut Hormone Changes After Gastric Bypass Explain the Dramatic Appetite Reduction

Postprandial GLP-1, PYY3-36, and other gut regulatory peptides dramatically increased following gastric bypass, with enhanced hormonal satiety signaling correlating with reduced appetite and caloric intake — hormonal reprogramming, not restriction, as the primary surgical mechanism.

Holdstock, C; Zethelius, B; Sundbom, M; Karlsson, F A; Edén Engström, B · Clinical Trial

RPEP-01357 · 2008

Genetics of Oxytocin and Vasopressin Receptors Shape Human Social Behavior

AVPR1a and OXTR genetic polymorphisms are associated with human social behavior variation: autism spectrum features, pair-bonding patterns, empathy levels, and social anxiety — establishing the genetic basis for neuropeptide-mediated social behavior.

Israel, Salomon; Lerer, Elad; Shalev, Idan; Uzefovsky, Florina; Reibold, Mathias; Bachner-Melman, Rachel; Granot, Roni; Bornstein, Gary; Knafo, Ariel; Yirmiya, Nurit; Ebstein, Richard P · Review

RPEP-01358 · 2008

How Well Do Opioid Peptides Cross the Gut Barrier? Transport Across Intestinal Cell Monolayers

Mu-opioid peptide agonists and antagonists showed variable Caco-2 monolayer permeability, with some achieving transcellular transport — assessing oral bioavailability potential and identifying which opioid peptide structures achieve gut barrier crossing.

Iwan, Małgorzata; Jarmołowska, Beata; Bielikowicz, Krzysztof; Kostyra, Elzbieta; Kostyra, Henryk; Kaczmarski, Maciej · In Vitro

RPEP-01359 · 2008

Curing H. pylori Changes Stomach Ghrelin and Can Cause Weight Gain

H. pylori eradication restored gastric ghrelin expression and increased circulating ghrelin levels, correlating with increased appetite and BMI gain — providing the hormonal mechanism for the weight gain commonly observed after successful H. pylori treatment.

Jang, Eun Jeong; Park, Sang Woon; Park, Ju Sang; Park, Sang Jong; Hahm, Ki-Baik; Paik, So Ya; Sin, Mi Kyung; Lee, Eon Sook; Oh, Sang Woo; Park, Cheol Young; Baik, Hyun Wook · Clinical Trial

RPEP-01360 · 2008

Fibrin-Inspired Self-Assembling Peptide Hydrogels for Wound Healing Scaffolds

Peptide-polymer hydrogels designed from fibrin's coiled-coil region self-assembled into scaffolds mimicking natural wound healing matrix, with tunable mechanical properties suitable for tissue engineering — bio-inspired design from the body's own clotting protein.

Jing, Peng; Rudra, Jai S; Herr, Andrew B; Collier, Joel H · In Vitro

RPEP-01362 · 2008

The Three-Amino-Acid Peptide KPV Reduced Intestinal Inflammation in Two Mouse Models of IBD

In the DSS-colitis model, KPV treatment led to significantly earlier recovery and stronger body weight regain compared to controls (p<0.01). Inflammatory cell infiltration was significantly reduced (p<0.05). In the adoptive transfer model (a T cell-driven colitis that more closely mimics human IBD), KPV-treated mice had significantly lower clinical scores, less body weight loss, and lower grades of tissue inflammation on histology. In vitro, KPV inhibited TNF-alpha-induced IL-8 secretion in intestinal epithelial cells, demonstrating a direct anti-inflammatory mechanism at the cellular level.

Kannengiesser, K; Maaser, C; Heidemann, J; Luegering, A; Ross, M; Brzoska, T; Böhm, M; Luger, T A; Domschke, W; Kucharzik, T · Animal Study

RPEP-01363 · 2008

How Different Macronutrients Trigger Different Gut Satiety Hormones

Different macronutrients trigger distinct gut peptide profiles: protein produces the strongest and most diverse satiety peptide response (GLP-1, PYY, CCK); fat strongly triggers CCK/GLP-1; carbohydrate mainly GIP/insulin; fiber enhances GLP-1/PYY through fermentation — macronutrient-specific appetite pharmacology.

Karhunen, L J; Juvonen, K R; Huotari, A; Purhonen, A K; Herzig, K H · Review

RPEP-01364 · 2008

Hormone-Based Weight and Diabetes Drugs: From GLP-1 to Amylin to Ghrelin Blockers

Hormone-based fuel metabolism drugs span GLP-1 agonists (semaglutide class), amylin analogs (pramlintide), PYY analogs, and ghrelin modulators for integrated obesity/diabetes treatment — exploiting endogenous regulatory peptide systems for superior metabolic control.

Kesty, Nicole C; Roth, Jonathan D; Maggs, David · Review

RPEP-01365 · 2008

Nicotine's Pain Relief Works Partly Through Spinal Met-Enkephalin Release

Nicotine antinociception involved spinal met-enkephalin release confirmed by intrathecal anti-met-enkephalin antibody blocking, extending the drug-endogenous opioid amplification mechanism to nicotine — explaining some of smoking's pain-modifying effects.

Kiguchi, Norikazu; Maeda, Takehiko; Tsuruga, Mie; Yamamoto, Akihiro; Yamamoto, Chizuko; Ozaki, Masanobu; Kishioka, Shiroh · Animal Study

RPEP-01366 · 2008

BPC-157 (PL14736 IBD Drug) Also Heals Healing-Impaired Wounds: Expanded Clinical Potential

BPC-157 (PL14736, in IBD clinical trials) effectively healed various types of healing-impaired wounds in rats including steroid-impaired, denervated, and complex soft tissue injuries — expanding its clinical development potential from IBD to wound healing indications.

Klicek, Robert; Sever, Marko; Radic, Bozo; Drmic, Domagoj; Kocman, Ivan; Zoricic, Ivan; Vuksic, Tihomir; Ivica, Mihovil; Barisic, Ivan; Ilic, Spomenko; Berkopic, Lidija; Vrcic, Hrvoje; Brcic, Luka; Blagaic, Alenka Boban; Coric, Marijana; Brcic, Iva; Rokotov, Dinko Stancic; Anic, Tomislav; Seiwerth, Sven; Sikiric, Predrag · Animal Study

RPEP-01370 · 2008

New Diabetes Drugs in 2008: GLP-1 Agonists, DPP-4 Inhibitors, and the New Treatment Era

New diabetes drugs include GLP-1 agonists (exenatide, liraglutide: injectable, weight loss, low hypo risk), DPP-4 inhibitors (sitagliptin, vildagliptin: oral, weight neutral), and amylin analog (pramlintide) — peptide-based drugs transforming type 2 diabetes treatment.

Krentz, Andrew J; Patel, Mayank B; Bailey, Clifford J · Review

RPEP-01371 · 2008

BPC-157 Improves Achilles Tendon-to-Bone Healing Even During Steroid Treatment

BPC-157 improved early functional recovery (load-to-failure, stiffness) of transected Achilles tendon-to-bone unit, with efficacy maintained during concurrent methylprednisolone — confirming dual tendon-healing and steroid-impairment-overcoming capabilities.

Krivic, A; Majerovic, M; Jelic, I; Seiwerth, S; Sikiric, P · Animal Study

RPEP-01372 · 2008

Alcohol Triggers Opioid Peptide Release in the Brain's Emotion Center

In-vivo microdialysis showed acute ethanol directly triggered beta-endorphin and met-enkephalin release in the central amygdala, providing real-time evidence for alcohol's emotional/anxiolytic effects through local opioid peptide release in the brain's fear center.

Lam, Minh P; Marinelli, Peter W; Bai, Li; Gianoulakis, Christina · Animal Study

RPEP-01373 · 2008

Ghrelin Gene Variants Linked to Heavy Drinking and Body Weight in Humans

Pro-ghrelin and GHS-R1A gene polymorphisms and haplotypes were associated with heavy alcohol use and BMI in humans, providing genetic evidence linking the ghrelin system to both alcohol addiction vulnerability and body weight regulation.

Landgren, Sara; Jerlhag, Elisabet; Zetterberg, Henrik; Gonzalez-Quintela, Arturo; Campos, Joaquin; Olofsson, Ulrica; Nilsson, Staffan; Blennow, Kaj; Engel, Jörgen A · Cross Sectional

RPEP-01375 · 2008

Inhaled VIP Peptide Selectively Relaxed Lung Blood Vessels in Pulmonary Hypertension Patients

A single inhaled dose of aviptadil (100 μg), a synthetic form of vasoactive intestinal peptide (VIP), caused selective pulmonary vasodilation in patients with chronic pulmonary hypertension. The peptide improved stroke volume and mixed venous oxygen saturation — indicating reduced strain on the right ventricle — without affecting systemic blood pressure. Six of 20 patients (30%) achieved a clinically meaningful >20% reduction in pulmonary vascular resistance. In patients with significant lung disease, aviptadil also tended to improve oxygenation. The effect was modest and temporary (as expected from a single dose), but no side effects were reported. The selective pulmonary vasodilation means the drug targeted the lung blood vessels specifically without dropping blood pressure throughout the rest of the body.

Leuchte, H H; Baezner, C; Baumgartner, R A; Bevec, D; Bacher, G; Neurohr, C; Behr, J · Clinical Trial (Uncontrolled)